¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Neonatal jaundice associated with preterm delivery"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • premature delivery
    ¹Ì¼÷¾ÆºÐ¸¸
  • vaginal delivery
    Áú(½Ä)ºÐ¸¸
  • acholuric familial jaundice
    ¹«´ãÁó´¢°¡Á·¼ºÈ²´Þ
  • acholuric jaundice
    ¹«´ãÁó´¢È²´Þ
  • blue jaundice
    ûȲ´Þ
  • breast milk jaundice
    ¸ðÀ¯È²´Þ
  • cholangitic jaundice
    ´ã°ü¿°È²´Þ, ¾µ°³°ü¿°È²´Þ
  • cholestatic jaundice
    ´ãÁóÁ¤Ã¼È²´Þ, ¾µ°³ÁóÁ¤Ã¼È²´Þ
  • drug-induced jaundice
    ¾à¹°À¯¹ßȲ´Þ
  • epidemic jaundice
    À¯ÇàȲ´Þ
  • green jaundice
    ³ì»öȲ´Þ
  • hemapheic jaundice
    ¿ì·Îºô¸°È²´Þ
  • hematohepatogenous jaundice
    Ç÷¾×°£¼ºÈ²´Þ
  • hemolytic jaundice
    ¿ëÇ÷Ȳ´Þ
  • hepatic dissociation jaundice
    °£Çظ®È²´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • high forceps delivery
    °íÀ§Áý°ÔºÐ¸¸¼ú
  • immature delivery
    ¹Ì¼÷ºÐ¸¸
  • induced delivery
    À¯µµºÐ¸¸
  • low forceps delivery
    ÀúÀ§Áý°ÔºÐ¸¸¼ú
  • midforceps delivery
    ÁßÀ§Áý°ÔºÐ¸¸, ÁßÀ§°âÀںи¸
  • premature delivery
    Á¶¼÷ºÐ¸¸, ¹Ì¼÷¾ÆºÐ¸¸
  • transdermal delivery
    °æÇÇÀü´Þ
  • vaginal delivery
    ÁúºÐ¸¸
  • epidemic jaundice
    À¯ÇàȲ´Þ
  • green jaundice
    ³ì»öȲ´Þ
  • health care delivery system
    ÀÇ·áÀü´Þü°è
  • hemapheic jaundice
    (¢¡urobilin jaundice) ¿ì·Îºô¸°È²´Þ
  • hematohepatogenous jaundice
    Ç÷¾×°£È²´Þ
  • hemolytic jaundice
    ¿ëÇ÷Ȳ´Þ
  • hepatic dissociation jaundice
    °£Çظ®È²´Þ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • precocious jaundice ³ª icterus praecox
    Á¶¹ßȲ´Þ(¡­üÜÓ¸).
  • recurrent jaundice of pregnancy
    ¹Ýº¹¼º Àӽżº(ÚãÜÖàõìôããàõ)Ȳ´Þ.
  • recurrent jaundice of pregnancy
    ¹Ýº¹¼º ÀӽżºÈ²´Þ(ÚãÜÖàõìôããàõüÜÓ¸)
  • regurgitation jaundice
    ¿ª·ù¼º Ȳ´Þ(¡­¼ºÈ²´Þ).
  • regurgitation jaundice
    ¿ª·ù¼º Ȳ´Þ(æ½×µàõüÜÓ¸)
  • renal dissociation jaundice
    ½ÅÇØ¸®¼º Ȳ´Þ(ãìú°ìÆàõüÜÓ¸).
  • renal dissociation jaundice
    ½ÅÇØ¸®¼º Ȳ´Þ(ãìú°ìÆàõüÜÓ¸)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • adeno-associated virus
    ¾Æµ¥³ë(¹ÙÀÌ·¯½º) ÀÇÁ¸ ¹ÙÀÌ·¯½º
  • adeno-associated virus
    ¾Æµ¥³ë°ü·Ã(¡­Î¼æá) ¹ÙÀÌ·¯½º.
  • adeno-associated virus
    ¾Æµ¥³ë°ü·Ã(¡­Î¼æá) ¹ÙÀÌ·¯½º.
  • age-associated memory impairment
    ¿¬·É°ü·Ã ±â¾ï·Â Àå¾Ö(¼Õ»ó)
  • antibiotic-associated colitis/diarrhea
    Ç×»ýÁ¦À¯¹ß´ëÀå¿°, Ç×»ýÁ¦À¯¹ß¼³»ç
  • antigen, I region-associated
    Ir¿¬°üÇ׿ø
  • antigen,fetal tumor-associated
    žÆÁ¾¾ç °ü·Ã¼º(÷Ãä®ðþåË Î¼Ö¤àõ)
  • associated antagonist
    °ø¾×±æÇ×¹°Áú.
  • associated movement
    ¿¬Çտ
  • associated psychosis
    ¼ö¹Ý(âËÚᣩÁ¤½Åº´
  • cell associated antigen
    ¼¼Æ÷¿¬°üÇ׿ø
  • cell-associated antibody
    ¼¼Æ÷°áÇÕÇ×ü(á¬øàÌ¿ùêù÷ô÷), ¼¼Æ÷°íÁ¤Ç×ü, ¼¼Æ÷°ü ·ÃÇ×ü.
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
  • croup-associated virus
    Å©·çÇÁ°ü·Ã¹ÙÀÌ·¯½º
  • dialysis-associated cystic disease of kidney
    ½Å(ãì)ÀÇ Åõ¼®(÷âà°) ¿¬°ü¼º ³¶¼ºÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PTL peritoneal telencephalic leukoencephalomyopathy; pharyngotracheal lumen; plasma thyroxine level post...
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
DAA decompensated autonomous adenoma; dementia associated with alcoholism; dialysis-associated amyloidos...
LFA left femoral artery; left frontal craniotomy; left fronto-anterior [fetal position]; leukocyte funct...
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TDS trans)dermal delivery system
BFNC Benign Familial Neonatal Convulsions
BNBAS Brazelton Neonatal Behavioral Assessment Scale
NAS Neonatal Abstinence Syndrome
NBAS Neonatal Behavioral Assessment Scale
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal blennorrhea
    ½Å»ý¾Æ ¾È ³ó·ç
  • neonatal calf diarrhea corona virus
    ½Å»ý¾Æ ¼³»ç Äڷγª ¹ÙÀÌ·¯½º
  • neonatal death
    ½Å»ý¾Æ »ç¸Á
  • neonatal diarrhea
    ½Å»ý¾Æ ¼³»ç
  • neonatal eruptive hemangiomatosis
    ¹ßÁø¼º ½Å»ý¾Æ Ç÷°üÁ¾Áõ
  • neonatal hepatitis
    ½Å»ý¾Æ °£¿°
  • neonatal infection
    ½Å»ý¾Æ °¨¿°
  • neonatal line
    ù ¼ºÀå¼±
  • neonatal maxillitis
    ½Å»ý¾Æ »ó¾Ç°ñ
  • neonatal mortality rate
    ½Å»ý¾Æ »ç¸Á·ü
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾Æ ÀÚ¹Ý
  • neonatal tetany
    ½Å»ý¾Æ Åן´Ï
  • neonatal thyrombocytopenia
    ½Å»ý¾Æ Ç÷¼ÒÆÇ °¨¼ÒÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
neonatal <paediatrics> Pertaining to the first four weeks after birth.
Origin: L. Natus = born
(18 Nov 1997)
neonatal abstinence syndrome <syndrome> Foetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
(12 Dec 1998)
neonatal anaemia <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
neonatal apoplexy Intracranial haemorrhage in newborn children.
(05 Mar 2000)
neonatal arthritis of foals Bacterial polyarthritis caused by umbilical infections by several bacterial species.
(05 Mar 2000)
neonatal calf diarrhoea virus One of two virus's causing neonatal calf diarrhoea; a reovirus-like virus is associated with disease in newborn calves, and a coronavirus is associated with disease in calves over 5 days of age.
(05 Mar 2000)
neonatal conjunctivitis Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is neisseria gonorrhoeae. The baby's eyes are contaminated during passage through the birth canal.
(12 Dec 1998)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
neonatal diagnosis Systematic evaluation of the newborn for evidence of disease or malformations, and the conclusion reached.
(05 Mar 2000)
neonatal diseases and abnormalities Diseases existing at birth and often before birth, regardless of causation. Of these congenital diseases, those characterised by structural deformities are termed abnormalities.
(12 Dec 1998)
neonatal heart failure <radiology> most likely cause, premature: patent ductus arteriosus, full term: hypoplastic left heart, 2nd week: coarctation and VSD aetiology, valvular stenosis, mitral stenosis, aortic stenosis, aortic coarctation, vein of Galen aneurysm, infantile haemangioendothelioma of liver, hypoplastic left heart see also: congestive heart failure in kids
(12 Dec 1998)
neonatal hepatitis Hepatitis in the neonatal period presumed to be due to a variety of causes, chiefly viral; characterised by direct and indirect bilirubinaemia, hepatocellular degeneration, and appearance of multinucleated giant cells; may be difficult to distinguish from biliary atresia, but is more likely to end with recovery, although cirrhosis may develop.
Synonym: giant cell hepatitis.
(05 Mar 2000)
neonatal herpes Herpes simplex virus type 1 or 2 infection transmitted from the mother to the newborn infant, often during passage through an infected birth canal; severity varies from mild to fatal generalised infection, the latter especially with primary maternal genital herpes.
(05 Mar 2000)
neonatal hypoglycaemia Familial onset of symptomatic hypoglycaemia during infancy, with persistently low blood glucose; a variant form is leucine-induced with hyperinsulinism and variable mental retardation.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á